Usefulness of Carotid Ultrasound Screening in Primary Cardiovascular Prevention: A Systematic Review [0.03%]
颈部血管超声筛查在心血管病一级预防中的作用：系统综述
Sneha Annie Sebastian,Edzel Lorraine Co,Atiyah Tidd-Johnson et al.
Sneha Annie Sebastian et al.
Background: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide, and its prevention is more cost-effective than the treatment of its complications. Although cardiovascular (CV) risk asse...
Comment on: Circumstances of Hospitalization Impact Outcomes of Pulmonary Embolism [0.03%]
关于：住院情况影响肺栓塞结局
Nimra Masood,Mubashra Khalid
Nimra Masood
Letter to Editor on Fawad et al. Comment on "Cost-Effectiveness Analysis of Ibuprofen versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates" by Al-Shaibi et al [0.03%]
Fawad等对“Al-Shaibi等关于早产儿动脉导管未闭治疗的布洛芬 vs 扑热息痛或吲哚美辛的成本效益分析”的评述的回信
Samaher Al-Shaibi,Dina Abushanab,Fouad Abounahia et al.
Samaher Al-Shaibi et al.
Complications of Right Heart Catheterization in Patients ≥70 Years of Age With Suspected Pulmonary Hypertension: Experience From a Tertiary Care Center [0.03%]
经右心导管检查疑似肺高压的≥70岁患者并发症：来自三级医疗机构的经验
Guillermo Cueto-Robledo,Leslie-Marisol González-Hermosillo,Mateo Porres-Aguilar et al.
Guillermo Cueto-Robledo et al.
Right heart catheterization (RHC) represents the gold standard diagnostic approach for pulmonary hypertension (PH). Historically, the complication rates of RHC are known to be low. The study aimed to evaluate the indications for performing ...
Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial [0.03%]
高血压和Lorudrostat：TARGET-HTN研究的关键发现
Hamza Irfan,Aliza Ahmed,Komal Devi Nawani
Hamza Irfan
Hypertension, characterized by persistent high blood pressure levels, is a major global health concern, contributing significantly to the risk of cardiovascular diseases (CVD) and overall mortality. It is classified into primary and seconda...
Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity: A Three Dimentional Echocardiography Study [0.03%]
他汀类药物治疗在蒽环类心脏毒性防治中作用的三维超声评价研究
Ahmed L Mohamed,Ali A El-Abd,Haitham G Mohamed et al.
Ahmed L Mohamed et al.
Background: Recent advances in the treatment of breast cancer have resulted in improved overall cancer survival; however, cancer therapy related cardiac dysfunction is considered a major adverse effect of several chemothe...
Randomized Controlled Trial
Current problems in cardiology. 2024 Jan;49(1 Pt C):102130. DOI:10.1016/j.cpcardiol.2023.102130 2024
Transcatheter Edge-to-Edge Repair in Patients With End-Stage Renal Disease on Dialysis: A USRDS Registry Study [0.03%]
终末期肾病透析患者的经导管缘对缘修复术：USRDS登记册研究
Eric D Warner,Mark Liotta,Umma Fatema et al.
Eric D Warner et al.
Transcatheter edge-to-edge repair (TEER) of the mitral valve has become standard of care for the treatment of high-risk patients with severe mitral regurgitation. Patients with end stage renal disease (ESRD) on hemodialysis were either excl...
Akanimo Antia,Chinonso Ndukauba,Ruth Pius et al.
Akanimo Antia et al.
Background: The management of cardiogenic shock (CS) requires attentiveness to details and in some cases, invasive interventions. In the past, studies have shown relationships between the day of admission and cardiovascul...
Rethinking HDL-C: An In-Depth Narrative Review of Its Role in Cardiovascular Health [0.03%]
重新思考HDL-C：对其在心血管健康中的作用的深入叙述性回顾
Prinka Perswani,Syed Muhammad Ismail,Hassan Mumtaz et al.
Prinka Perswani et al.
The interplay between HDL-C and LDL levels are closely intertwined with the cardiovascular system. High-Density Lipoprotein Cholesterol (HDL-C) is a well-known biomarker traditionally being interpreted as higher the HDL-C levels, minimal th...
Nanoparticle Polymers Influence on Cardiac Health: Good or Bad for Cardiac Physiology? [0.03%]
纳米颗粒聚合物对心脏健康的影响：对心脏生理是好是坏？
Manasa Kanithi,Lata Kumari,Keerthika Yalakaturi et al.
Manasa Kanithi et al.
Cardiovascular diseases (CVD) are one of the leading causes of death and morbidity worldwide. Lifestyle modifications, medications, and addressing epidemiological factors have long been at the forefront of targeting therapeutics for CVD. Tr...